265 related articles for article (PubMed ID: 27859917)
1. Current evidence for the use of sugammadex in children.
Tobias JD
Paediatr Anaesth; 2017 Feb; 27(2):118-125. PubMed ID: 27859917
[TBL] [Abstract][Full Text] [Related]
2. The use of sugammadex in a patient with myasthenia gravis.
Unterbuchner C; Fink H; Blobner M
Anaesthesia; 2010 Mar; 65(3):302-5. PubMed ID: 20105151
[TBL] [Abstract][Full Text] [Related]
3. Can sugammadex save a patient in a simulated 'cannot intubate, cannot ventilate' situation?
Bisschops MM; Holleman C; Huitink JM
Anaesthesia; 2010 Sep; 65(9):936-41. PubMed ID: 21198485
[TBL] [Abstract][Full Text] [Related]
4. Reversal of rocuronium-induced profound neuromuscular block by sugammadex in Duchenne muscular dystrophy.
de Boer HD; van Esmond J; Booij LH; Driessen JJ
Paediatr Anaesth; 2009 Dec; 19(12):1226-8. PubMed ID: 19863737
[TBL] [Abstract][Full Text] [Related]
5. Reversal of rocuronium-induced neuromuscular blockade with sugammadex in pediatric and adult surgical patients.
Plaud B; Meretoja O; Hofmockel R; Raft J; Stoddart PA; van Kuijk JH; Hermens Y; Mirakhur RK
Anesthesiology; 2009 Feb; 110(2):284-94. PubMed ID: 19194156
[TBL] [Abstract][Full Text] [Related]
6. Sugammadex: a novel agent for the reversal of neuromuscular blockade.
Nicholson WT; Sprung J; Jankowski CJ
Pharmacotherapy; 2007 Aug; 27(8):1181-8. PubMed ID: 17655516
[TBL] [Abstract][Full Text] [Related]
7. Sugammadex: a novel neuromuscular blocker binding agent.
Fields AM; Vadivelu N
Curr Opin Anaesthesiol; 2007 Aug; 20(4):307-10. PubMed ID: 17620836
[TBL] [Abstract][Full Text] [Related]
8. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine.
Sacan O; White PF; Tufanogullari B; Klein K
Anesth Analg; 2007 Mar; 104(3):569-74. PubMed ID: 17312210
[TBL] [Abstract][Full Text] [Related]
9. Sugammadex provides faster reversal of vecuronium-induced neuromuscular blockade compared with neostigmine: a multicenter, randomized, controlled trial.
Khuenl-Brady KS; Wattwil M; Vanacker BF; Lora-Tamayo JI; Rietbergen H; Alvarez-Gómez JA
Anesth Analg; 2010 Jan; 110(1):64-73. PubMed ID: 19713265
[TBL] [Abstract][Full Text] [Related]
10. A comparison of sugammadex and neostigmine for reversal of rocuronium-induced neuromuscular blockade in children.
Ammar AS; Mahmoud KM; Kasemy ZA
Acta Anaesthesiol Scand; 2017 Apr; 61(4):374-380. PubMed ID: 28185260
[TBL] [Abstract][Full Text] [Related]
11. Cochrane corner: sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade.
Abrishami A; Ho J; Wong J; Yin L; Chung F
Anesth Analg; 2010 Apr; 110(4):1239. PubMed ID: 20357160
[TBL] [Abstract][Full Text] [Related]
12. Clinical pharmacology and efficacy of sugammadex in the reversal of neuromuscular blockade.
Schaller SJ; Lewald H
Expert Opin Drug Metab Toxicol; 2016 Sep; 12(9):1097-108. PubMed ID: 27463265
[TBL] [Abstract][Full Text] [Related]
13. Can sugammadex save a patient in a simulated 'cannot intubate, cannot ventilate' scenario?
Dada A; Dunsire F
Anaesthesia; 2011 Feb; 66(2):141-2. PubMed ID: 21254997
[No Abstract] [Full Text] [Related]
14. A novel approach to reversal of neuromuscular blockade.
Della Rocca G; Pompei L
Minerva Anestesiol; 2009 May; 75(5):349-51. PubMed ID: 19412157
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of sugammadex compared to neostigmine for reversal of neuromuscular blockade: a meta-analysis of randomized controlled trials.
Carron M; Zarantonello F; Tellaroli P; Ori C
J Clin Anesth; 2016 Dec; 35():1-12. PubMed ID: 27871504
[TBL] [Abstract][Full Text] [Related]
16. The effect of rocuronium and sugammadex on neuromuscular blockade in a child with congenital myotonic dystrophy type 1.
Pickard A; Lobo C; Stoddart PA
Paediatr Anaesth; 2013 Sep; 23(9):871-3. PubMed ID: 23763618
[TBL] [Abstract][Full Text] [Related]
17. Reversal of neuromuscular blockade with sugammadex at the reappearance of four twitches to train-of-four stimulation.
Pongrácz A; Szatmári S; Nemes R; Fülesdi B; Tassonyi E
Anesthesiology; 2013 Jul; 119(1):36-42. PubMed ID: 23665915
[TBL] [Abstract][Full Text] [Related]
18. Can sugammadex save a patient in a simulated 'cannot intubate, cannot ventilate' situation?
Mercer SJ; Moneypenny MJ
Anaesthesia; 2011 Mar; 66(3):223-4. PubMed ID: 21320093
[No Abstract] [Full Text] [Related]
19. Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block.
Kotake Y; Ochiai R; Suzuki T; Ogawa S; Takagi S; Ozaki M; Nakatsuka I; Takeda J
Anesth Analg; 2013 Aug; 117(2):345-51. PubMed ID: 23757472
[TBL] [Abstract][Full Text] [Related]
20. The safety and efficacy of sugammadex for reversing neuromuscular blockade in younger children and infants.
Wang A; Tsivitis A; Ma S; Jin Z; Al Bizri E; Moore R
Expert Opin Drug Saf; 2024 Jul; 23(7):845-853. PubMed ID: 38938223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
